Intravenous amiodarone for the prevention of the postoperative atrial fibrillation after cardiac surgery

Intravenous amiodarone for the prevention of the postoperative atrial fibrillation after cardiac surgery - amio-af prevention

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000018402

Enrollment

130

Registered

2015-08-01

Start date

2016-03-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

elective cardiac surgery

Interventions

Intravenous amiodarone 750mg per day is administered for 3 days after cardiac surgery. no intravenous amiodarone

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: combined valve surgery,aortic valve surgery for 70 years of age or more, off pump coronary artery bypass for 65 years of age or more.

Exclusion criteria

Exclusion criteria: past history of atrial fibrillation liver dysfunction shock vital allergy for amiodarone

Design outcomes

Primary

Measure	Time frame
the incidence of the postoperative atrial fibrillation during 7days after cardiac surgery	—

Countries

Japan

Contacts

Public ContactOmoto Tadashi

Showa university Cardiovascular surgery

thoracsurg@med.showa-u.ac.jp03-3784-8588

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026